XENON, XE-133

all catalysts(0)

nothing on the calendar yet

News(8)

• Xenon shares fall following depression trial pause
  The occurrence of “neuropsychiatric” adverse events in testing fueled investor doubts about a drug the FDA is already reviewing for a form of epilepsy.
  biopharma_dive · 1mo ago
• Xenon tumbles on voluntary psychiatry hold, but analysts confident in $2B epilepsy opportunity
  As Xenon Pharmaceuticals announced that azetukalner has reached the FDA for focal seizures, the company also disclosed the emergence of psychosis adverse events in psychiatric trials of the drug, t…
  biospace · 1mo ago
• STAT+: Roche expands its Boston footprint with new research center
  A gene therapy approved for Sanfilippo syndrome, good and bad news for Xenon Pharma, and more biotech news
  stat · 1mo ago
• Xenon pauses phase 3 depression trials after psychosis events
  The company has voluntarily stopped enrolling new patients in the studies in response to reports of mostly mild or moderate adverse events.
  fiercebiotech · 1mo ago
• SK Biopharma pens $795M deal to usher Biohaven’s epilepsy therapy towards hoped-for 2029 launch
  SK Biopharmaceuticals has strengthened its epilepsy offering by paying $350 million upfront to help speed Biohaven’s Kv7 ion channel activator on its way to market.
  fiercebiotech · 2mo ago
• EyePoint plummets on pivotal data for main drug
  Though its drug missed the key goal of a wet AMD study, EyePoint — as well as analysts — see a path toward approval. Investors may be harder to win over, however.
  biopharma_dive · 2mo ago
• NewLimit’s $435M megaround; Lilly’s busy dealmaking week
  The anti-aging biotech has secured one of the year’s biggest venture fundings to bring its first drug into testing. Elsewhere, Lilly nabbed a “GLP-2” obesity drug and Praxis shares tumbled.
  biopharma_dive · 5mo ago
• A year after Vertex’s big launch, pain drug research faces a pivotal moment
  Journavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going?
  biopharma_dive · 5mo ago